Related Experiment Videos

The metastasis suppressor gene C33/CD82/KAI1 induces apoptosis through reactive oxygen intermediates

Nicole Schoenfeld1, Manuel K A Bauer, Stefan Grimm

  • 1Max-Planck-Institute for Biochemistry, Martinsried, Germany.

Insights

The gene C33 (also known as CD82/KAI1) induces apoptosis by promoting reactive oxygen intermediates (ROIs) generation. It achieves this by causing glutathione (GSH) release, independent of mitochondrial pathways.

Area of Science:

  • Molecular Biology
  • Cell Biology
  • Oncology

Background:

  • C33/CD82/KAI1 is a gene frequently downregulated in metastatic cancers.
  • Its expression is linked to reduced metastasis formation across various tumor types.
  • Apoptosis-inducing genes are crucial targets for cancer therapy.

Purpose of the Study:

  • To investigate the mechanism by which C33 induces apoptosis.
  • To identify the signaling pathways involved in C33-mediated cell death.
  • To explore the role of reactive oxygen intermediates (ROIs) in C33-induced apoptosis.

Main Methods:

  • Gene screening to identify apoptosis-inducing genes.
  • Cell viability assays across different cell types.
  • Measurement of reactive oxygen intermediates (ROIs) and glutathione (GSH) levels.
  • Analysis of GTPase Cdc42 activation.

Main Results:

  • C33 expression induced cell death in multiple cell types.
  • C33-mediated apoptosis involved reactive oxygen intermediates (ROIs) generation.
  • ROIs were not derived from the mitochondrial respiratory chain.
  • C33 triggered the release of intracellular glutathione (GSH), sensitizing cells to ROIs.
  • C33 activated the GTPase Cdc42, which mediated GSH release and apoptosis.

Conclusions:

  • C33/CD82/KAI1 is a novel apoptosis-inducing gene.
  • C33 promotes cell death via a non-mitochondrial ROI generation pathway.
  • GSH release and Cdc42 activation are key mechanisms in C33-induced apoptosis.
  • C33 represents a potential therapeutic target for metastatic cancers.

Related Concept Videos